global+growth

We should override patent protection on some medicines and change how R&D is funded.

“I’m working, I have benefits. I can get my teeth cleaned and my eyes checked, but I can’t get the medicine that keeps me and my sister alive,” said one patient with diabetes.

The World Health Organization (WHO) has announced the start of a pilot programme to prequalify human insulin to increase treatment for diabetes in low- and middle-income countries.

Patents and Patients: US pharmaceutical companies are more interested in protecting their valuable drugs patents than treating Indian AIDS sufferers.

You'd think that as a poor country grows wealthier, more of its children would get vaccinated for preventable diseases such as polio, measles and pneumonia.

Beijing’s health-care reforms are giving global pharmaceutical companies better access to the world’s second-largest drug market.

Foreign direct investment in the pharmaceutical industry is set to increase the availability of drugs in the country’s hospitals.

A 66% price slash of a little used but powerful drug that prevents tuberculosis (TB) could help stave off the deadly lung disease in millions of people around the world.

Drug manufacturer Sanofi announced today that they will slash the price of a TB prevention drug set to hit the South African market. The price has been reduced by almost 70% to just under R230 (US$15).

The vaccine will be used as part of a clinical trial, but the aim is as much to help extinguish the long-running outbreak in the country’s northeast as it is to gather data on the effectiveness of the vaccine.

Some diseases affect billions, yet they attract little interest from the pharmaceutical industry and public sector because those affected are poor, leaving doctors powerless to treat patients.

Key lessons, challenges, and opportunities for the future.

China’s aggressive campaign to bring down drug prices is leading to a “vicious cycle” and will prevent the emergence of a national pharmaceutical champion, said one of the country’s biggest drug makers.

An alternative to Big Pharma?

The only drug production facility in the Gaza Strip has managed to keep operating for 25 years despite challenges usually faced only in a warzone.